"As numerous public health champions have said repeatedly, we must take morality out of public health," Annette Gaudino writes. "Treating and curing active drug and alcohol users, and removing prison as the primary intervention for those with substan...
"Amidst the happy haze of good news about the efficacy of PrEP in preventing new HIV infections and the growing consensus that people living with HIV who are undetectable are not infectious, there is troubling news from the CDC in two new reports abo...
New hepatitis C treatments are changing the equation for people coinfected with HIV and hep C: shorter treatment times, reduced side effects and sky-high cure rates.
"History shows us that bacteria will find a way to outlast the antibiotics we're using to treat it. We are running just one step ahead in order to preserve the remaining treatment option,” says Jonathan Mermin of CDC.
On July 11, 2016, Health Canada licensed the sale and use of a new fixed-dose combination of two anti-hepatitis C virus (HCV) drugs sold under the brand name Epclusa.
"I fought the idea of working with a coach," Lucinda K. Porter writes. "It took me five years to decide to work with a coach. The experience was profound and it was fun."
People with hepatitis C virus and their allies from Spain and around the world have gathered at the International Liver Congress to protest the outrageous price of life-saving HCV medicines.
"Generic treatments for HIV, viral hepatitis, and cancer can be affordably -- and profitably -- mass-produced for broad, unobstructed availability," writes Tracy Swan in this interview with Andrew Hill.
Despite the high price tag of curative treatments, public health leaders stress that treating people behind bars is more effective and less costly than trying to remedy the damage to affected individuals and communities later on, Victoria Law reports...
Living with a chronic illness is difficult. Speaking about illness publicly may be even harder. But many celebrities have spoken up about their diagnosis and treatment for hepatitis C.